T he reader will note that Dr Kisely and I agree that every research method has its flaws when CTOs are assessed. Mirror-image studies, which use patients as their own control subjects, provide the best "subject match," but they are susceptible to the influence of temporal changes and regression to the mean. Case-control studies can match for demographic variables and diagnosis but not for important clinical variables such as degree of insight. We also agree that RCTs to assess CTOs are exceedingly difficult to perform and that the New York RCT (1) was fatally flawed.
Dr Kisely and I part ways at the point where, having acknowledged these difficulties, he still insists that we disregard all research evidence not generated in an RCT. Indeed, while acknowledging that the exclusion of violent patients in both RCTs reduced the observed effectiveness of CTOs, Dr Kisely encourages readers to ignore the findings of the parallel comparison of nonrandomized violent patients in the North Carolina RCT (2) . Dr Kisely also asks us to overlook the findings from the post hoc analysis on the extended CTOs from North Carolina (3). Of course, it is precisely when a study is difficult to perform and may never be repeated that we should consider what we can learn from post hoc analysis. I am not suggesting that the findings of post hoc analysis be given equal weight with the primary comparisons of the randomized subjects, but they certainly should not be discarded.
Dr Kisely reasonably questions whether the success of sustained CTOs could result from treatment orders being renewed when patients were doing well and not renewed when they were doing poorly. However, he fails to inform readers that patients who had their orders renewed were more likely than those whose orders were not renewed to have had a history of medication nonadherence prior to randomization (3).
Most tellingly, Dr Kisely elects not to tell readers that, in the North Carolina study, serious victimization of patients, an important clinical outcome, was significantly reduced in all subjects randomized to CTOs. It is therefore difficult to avoid the conclusion that Dr Kisely wishes to minimize or ignore some evidence rather than carefully considering and weighing findings from each level of evidence.
We are now in the fortunate position of knowing the results of CTOs in a real clinical setting. After the pilot RCT, New York State introduced CTOs and mandated an evaluation of outcome for every individual on a CTO in the state. Following placement on a treatment order, these patients were 87% less likely to be jailed, 77% less likely to be hospitalized, 74% less likely to be homeless, 55% less likely to attempt suicide, 48% less likely to abuse drugs or alcohol, and 47% less likely to physically harm others (4) . Indeed, after placement on a CTO, patients showed improvement on every one of the multiple outcome measures. Emperor=s clothes? I think not! The evidence that CTOs are effective is plain to see, provided one is willing to look!
